Status:
COMPLETED
Supine Percutaneous Nephrolithotomy
Lead Sponsor:
Ain Shams University
Conditions:
Renal Stone
Eligibility:
All Genders
2-16 years
Phase:
PHASE2
PHASE3
Brief Summary
there is an increased incidence of renal stones, especially in the pediatric age group. the percutaneous approach in the pediatric age took a long time till it again accepted among surgeons worldwide....
Detailed Description
The incidence of renal stones in the pediatric age group increased from 18.4 to 57.0% per100,000 children in the period from 1999 to 2008. The acceptance of PCNL in pediatrics was slow at first due to...
Eligibility Criteria
Inclusion
- patients aged from two to sixteen years old with single or multiple renal stones indicated for percutaneous nephrolithotomy
Exclusion
- patients with renal anomalies, bleeding tendency, elevated kidney function tests for age, previous renal surgical intervention on the same site of intervention.
- patients with skeletal abnormalities and spine deformities were also excluded
- patients with a single kidney were also excluded
Key Trial Info
Start Date :
June 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2021
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT04869969
Start Date
June 1 2019
End Date
September 30 2021
Last Update
July 14 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ain Shams University hospital
Cairo, Egypt, 11367